Novel insights into the immunomodulatory role of the dendritic cell and macrophage-expressed C-type lectin MGL

Immunobiology

Volumn 220, Issue 2, 2015, Pages 185-192

  van Kooyk, Yvette ^a   Ilarregui, Juan M ^a   van Vliet, Sandra J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

C type lectin; Dendritic cells; Macrophages; T cells; Tn antigen

Indexed keywords

INTERLEUKIN 10; LECTIN; MACROPHAGE GALACTOSE TYPE LECTIN; MACROPHAGE GALACTOSE TYPE LECTIN 1; MACROPHAGE GALACTOSE TYPE LECTIN 2; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARBOHYDRATE; LIGAND;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CANCER GROWTH; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; EFFECTOR CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ACTIVATION; MALIGNANT TRANSFORMATION; NEISSERIA GONORRHOEAE; NONHUMAN; PARASITOSIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TH2 CELL; ANIMAL; IMMUNOLOGY; METABOLISM; PROCEDURES; VACCINATION;

ADAPTIVE IMMUNITY; ANIMALS; CARBOHYDRATES; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; LECTINS, C-TYPE; LIGANDS; MACROPHAGES; SIGNAL TRANSDUCTION; VACCINATION;

EID: 84973227777     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.10.002     Document Type: Article

References (71)

1. Angel C.E., George E., Brooks A.E., Ostrovsky L.L., Brown T.L., Dunbar P.R. Cutting Edge: CD1a+ antigen-presenting cells in human dermis respond rapidly to CCR7 ligands. J. Immunol. 2006, 176:5730-5734.
2. Anthony R.M., Rutitzky L.I., Urban J.F., Stadecker M.J., Gause W.C. Protective immune mechanisms in helminth infection. Nat. Rev. Immunol. 2007, 7:975-987.
3. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M.C., Steinman R.M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 2002, 196:1627-1638.
4. Carter R.W., Thompson C., Reid D.M., Wong S.Y., Tough D.F. Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1. J. Immunol. 2006, 177:2276-2284.
5. Christen U., Wolfe T., Mohrle U., Hughes A.C., Rodrigo E., Green E.A., Flavell R.A., von Herrath M.G. A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J. Immunol. 2001, 166:7023-7032.
6. Denda-Nagai K., Aida S., Saba K., Suzuki K., Moriyama S., Oo-Puthinan S., Tsuiji M., Morikawa A., Kumamoto Y., Sugiura D., Kudo A., Akimoto Y., Kawakami H., Bovin N.V., Irimura T. Distribution and function of macrophage galactose-type C-type lectin 2 (MGL2/CD301b): efficient uptake and presentation of glycosylated antigens by dendritic cells. J. Biol. Chem. 2010, 285:19193-19204.
7. Dudziak D., Kamphorst A.O., Heidkamp G.F., Buchholz V.R., Trumpfheller C., Yamazaki S., Cheong C., Liu K., Lee H.W., Park C.G., Steinman R.M., Nussenzweig M.C. Differential antigen processing by dendritic cell subsets in vivo. Science 2007, 315:107-111.
8. Eriksson M., Serna S., Maglinao M., Schlegel M.K., Seeberger P.H., Reichardt N.C., Lepenies B. Biological evaluation of multivalent Lewis X-MGL-1 interactions. ChemBioChem 2014, 15:844-851.
9. Everts B., Hussaarts L., Driessen N.N., Meevissen M.H., Schramm G., van der Ham A.J., van der Hoeven B., Scholzen T., Burgdorf S., Mohrs M., Pearce E.J., Hokke C.H., Haas H., Smits H.H., Yazdanbakhsh M. Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. J. Exp. Med. 2012, 209:1753-1767.
10. Freire T., Lo-Man R., Bay S., Leclerc C. Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses. J. Biol. Chem. 2011, 286:7797-7811.
11. Freire T., Zhang X., Deriaud E., Ganneau C., Vichier-Guerre S., Azria E., Launay O., Lo-Man R., Bay S., Leclerc C. Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant. Blood 2010, 116:3526-3536.
12. Gao Y., Nish S.A., Jiang R., Hou L., Licona-Limon P., Weinstein J.S., Zhao H., Medzhitov R. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity 2013, 39:722-732.
13. Higashi N., Fujioka K., Denda-Nagai K., Hashimoto S., Nagai S., Sato T., Fujita Y., Morikawa A., Tsuiji M., Miyata-Takeuchi M., Sano Y., Suzuki N., Yamamoto K., Matsushima K., Irimura T. The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells. J. Biol. Chem. 2002, 277:20686-20693.
14. Hiltbold E.M., Vlad A.M., Ciborowski P., Watkins S.C., Finn O.J. The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells. J. Immunol. 2000, 165:3730-3741.
15. Iida S., Yamamoto K., Irimura T. Interaction of human macrophage C-type lectin with O-linked N-acetylgalactosamine residues on mucin glycopeptides. J. Biol. Chem. 1999, 274:10697-10705.
16. Kim E.Y., Chi H.H., Rajaiah R., Moudgil K.D. Exogenous tumour necrosis factor alpha induces suppression of autoimmune arthritis. Arthritis Res. Ther. 2008, 10:R38.
17. Klaver E.J., Kuijk L.M., Laan L.C., Kringel H., van Vliet S.J., Bouma G., Cummings R.D., Kraal G., Van Die I. Trichuris suis-induced modulation of human dendritic cell function is glycan-mediated. Int. J. Parasitol. 2013, 43:191-200.
18. Kleijwegt F.S., Laban S., Duinkerken G., Joosten A.M., Zaldumbide A., Nikolic T., Roep B.O. Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells. J. Immunol. 2010, 185:1412-1418.
19. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
20. Kumamoto Y., Denda-Nagai K., Aida S., Higashi N., Irimura T. MGL2 Dermal dendritic cells are sufficient to initiate contact hypersensitivity in vivo. PLoS One 2009, 4:e5619.
21. Kumamoto Y., Higashi N., Denda-Nagai K., Tsuiji M., Sato K., Crocker P.R., Irimura T. Identification of sialoadhesin as a dominant lymph node counter-receptor for mouse macrophage galactose-type C-type lectin 1. J. Biol. Chem. 2004, 279:49274-49280.
22. Kumamoto Y., Linehan M., Weinstein J.S., Laidlaw B.J., Craft J.E., Iwasaki A. CD301b(+) dermal dendritic cells drive T helper 2 cell-mediated immunity. Immunity 2013, 39:733-743.
23. Li D., Romain G., Flamar A.L., Duluc D., Dullaers M., Li X.H., Zurawski S., Bosquet N., Palucka A.K., Le Grand R., O'Garra A., Zurawski G., Banchereau J., Oh S. Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells. J. Exp. Med. 2012, 209:109-121.
24. Lo-Man R., Vichier-Guerre S., Bay S., Deriaud E., Cantacuzene D., Leclerc C. Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope. J. Immunol. 2001, 166:2849-2854.
25. Lo-Man R., Vichier-Guerre S., Perraut R., Deriaud E., Huteau V., BenMohamed L., Diop O.M., Livingston P.O., Bay S., Leclerc C. A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates. Cancer Res. 2004, 64:4987-4994.
26. Meevissen M.H., Driessen N.N., Smits H.H., Versteegh R., van Vliet S.J., van Kooyk Y., Schramm G., Deelder A.M., Haas H., Yazdanbakhsh M., Hokke C.H. Specific glycan elements determine differential binding of individual egg glycoproteins of the human parasite Schistosoma mansoni by host C-type lectin receptors. Int. J. Parasitol. 2012, 42:269-277.
27. Moore K.W., de Waal M.R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
28. Mortezai N., Behnken H.N., Kurze A.K., Ludewig P., Buck F., Meyer B., Wagener C. Tumor-associated Neu5Ac-Tn and Neu5Gc-Tn antigens bind to C-type lectin CLEC10A (CD301, MGL). Glycobiology 2013, 23:844-852.
29. Mumm J.B., Emmerich J., Zhang X., Chan I., Wu L., Mauze S., Blaisdell S., Basham B., Dai J., Grein J., Sheppard C., Hong K., Cutler C., Turner S., LaFace D., Kleinschek M., Judo M., Ayanoglu G., Langowski J., Gu D., Paporello B., Murphy E., Sriram V., Naravula S., Desai B., Medicherla S., Seghezzi W., McClanahan T., Cannon-Carlson S., Beebe A.M., Oft M. IL-10 elicits IFNgamma-dependent tumor immune surveillance. Cancer Cell 2011, 20:781-796.
30. Murakami R., Denda-Nagai K., Hashimoto S., Nagai S., Hattori M., Irimura T. A unique dermal dendritic cell subset that skews the immune response toward Th2. PLoS One 2013, 8:e73270.
31. Napoletano C., Rughetti A., Agervig Tarp M.P., Coleman J., Bennett E.P., Picco G., Sale P., Denda-Nagai K., Irimura T., Mandel U., Clausen H., Frati L., Taylor-Papadimitriou J., Burchell J., Nuti M. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells. Cancer Res. 2007, 67:8358-8367.
32. Napoletano C., Zizzari I.G., Rughetti A., Rahimi H., Irimura T., Clausen H., Wandall H.H., Belleudi F., Bellati F., Pierelli L., Frati L., Nuti M. Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation. Eur. J. Immunol. 2012, 42:936-945.
33. Neven B., Mamessier E., Bruneau J., Kaltenbach S., Kotlarz D., Suarez F., Masliah-Planchon J., Billot K., Canioni D., Frange P., Radford-Weiss I., Asnafi V., Murugan D., Bole C., Nitschke P., Goulet O., Casanova J.L., Blanche S., Picard C., Hermine O., Rieux-Laucat F., Brousse N., Davi F., Baud V., Klein C., Nadel B., Ruemmele F., Fischer A. A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency. Blood 2013, 122:3713-3722.
34. Ng W.C., Liong S., Tate M.D., Irimura T., Denda-Nagai K., Brooks A.G., Londrigan S.L., Reading P.C. The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus. J. Virol. 2014, 88:1659-1672.
35. Nollau P., Wolters-Eisfeld G., Mortezai N., Kurze A.K., Klampe B., Debus A., Bockhorn M., Niendorf A., Wagener C. Protein domain histochemistry (PDH): binding of the carbohydrate recognition domain (CRD) of recombinant human glycoreceptor CLEC10A (CD301) to formalin-fixed, paraffin-embedded breast cancer tissues. J. Histochem. Cytochem. 2013, 61:199-205.
36. O'Shea J.J., Ma A., Lipsky P. Cytokines and autoimmunity. Nat. Rev. Immunol. 2002, 2:37-45.
37. Oo-Puthinan S., Maenuma K., Sakakura M., Denda-Nagai K., Tsuiji M., Shimada I., Nakamura-Tsuruta S., Hirabayashi J., Bovin N.V., Irimura T. The amino acids involved in the distinct carbohydrate specificities between macrophage galactose-type C-type lectins 1 and 2 (CD301a and b) of mice. Biochim. Biophys. Acta 2008, 1780:89-100.
38. Perez-Alvarez R., Perez-de-Lis M., Ramos-Casals M. Biologics-induced autoimmune diseases. Curr. Opin. Rheumatol. 2013, 25:56-64.
39. Raes G., Brys L., Dahal B.K., Brandt J., Grooten J., Brombacher F., Vanham G., Noel W., Bogaert P., Boonefaes T., Kindt A., Van den Bergh R., Leenen P.J., De Baetselier P., Ghassabeh G.H. Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J. Leukoc. Biol. 2005, 77:321-327.
40. Saba K., da-Nagai K., Irimura T. A C-type lectin MGL1/CD301a plays an anti-inflammatory role in murine experimental colitis. Am. J. Pathol. 2009, 174:144-152.
41. Saeland E., Belo A.I., Mongera S., Van Die I., Meijer G.A., van Kooyk Y. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients. Int. J. Cancer 2012, 131:117-128.
42. Saeland E., van Vliet S.J., Backstrom M., van den Berg V.C., Geijtenbeek T.B., Meijer G.A., van Kooyk Y. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma. Cancer Immunol. Immunother. 2007, 56:1225-1236.
43. Sakakura M., Oo-Puthinan S., Moriyama C., Kimura T., Moriya J., Irimura T., Shimada I. Carbohydrate binding mechanism of the macrophage galactose-type C-type lectin 1 revealed by saturation transfer experiments. J. Biol. Chem. 2008, 283:33665-33673.
44. Sancho D., Reis e Sousa C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu. Rev. Immunol. 2012, 30:491-529.
45. Sato K., Imai Y., Higashi N., Kumamoto Y., Onami T.M., Hedrick S.M., Irimura T. Lack of antigen-specific tissue remodeling in mice deficient in the macrophage galactose-type calcium-type lectin 1/CD301a. Blood 2005, 106:207-215.
46. Satoh T., Takeuchi O., Vandenbon A., Yasuda K., Tanaka Y., Kumagai Y., Miyake T., Matsushita K., Okazaki T., Saitoh T., Honma K., Matsuyama T., Yui K., Tsujimura T., Standley D.M., Nakanishi K., Nakai K., Akira S. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 2010, 11:936-944.
47. Schutz F., Hackstein H. Identification of novel dendritic cell subset markers in human blood. Biochem. Biophys. Res. Commun. 2014, 443:453-457.
48. Singh S.K., Streng-Ouwehand I., Litjens M., Kalay H., Saeland E., van Kooyk Y. Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8T cell responses. Int. J. Cancer 2011, 128:1371-1383.
49. Singh S.K., Streng-Ouwehand I., Litjens M., Weelij D.R., Garcia-Vallejo J.J., van Vliet S.J., Saeland E., van Kooyk Y. Characterization of murine MGL1 and MGL2 C-type lectins: distinct glycan specificities and tumor binding properties. Mol. Immunol. 2009, 46:1240-1249.
50. Sokol C.L., Barton G.M., Farr A.G., Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat. Immunol. 2008, 9:310-318.
51. Suzuki S., Honma K., Matsuyama T., Suzuki K., Toriyama K., Akitoyo I., Yamamoto K., Suematsu T., Nakamura M., Yui K., Kumatori A. Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell development. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8981-8986.
52. Tacken P.J., de Vries I.J., Gijzen K., Joosten B., Wu D., Rother R.P., Faas S.J., Punt C.J., Torensma R., Adema G.J., Figdor C.G. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood 2005, 106:1278-1285.
53. Takada A., Fujioka K., Tsuiji M., Morikawa A., Higashi N., Ebihara H., Kobasa D., Feldmann H., Irimura T., Kawaoka Y. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J. Virol. 2004, 78:2943-2947.
54. Terrazas C.A., Alcantara-Hernandez M., Bonifaz L., Terrazas L.I., Satoskar A.R. Helminth-excreted/secreted products are recognized by multiple receptors on DCs to block the TLR response and bias Th2 polarization in a cRAF dependent pathway. FASEB J. 2013, 27:4547-4560.
55. Tsuiji M., Fujimori M., Ohashi Y., Higashi N., Onami T.M., Hedrick S.M., Irimura T. Molecular cloning and characterization of a novel mouse macrophage C-type lectin, mMGL2, which has a distinct carbohydrate specificity from mMGL1. J. Biol. Chem. 2002, 277:28892-28901.
56. Unger W.W., van Kooyk Y. 'Dressed for success' C-type lectin receptors for the delivery of glyco-vaccines to dendritic cells. Curr. Opin. Immunol. 2011, 23:131-137.
57. Upham J.P., Pickett D., Irimura T., Anders E.M., Reading P.C. Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry. J. Virol. 2010, 84:3730-3737.
58. van Liempt E., van Vliet S.J., Engering A., Garcia Vallejo J.J., Bank C.M., Sanchez-Hernandez M., van Kooyk Y., Van Die I. Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Mol. Immunol. 2007, 44:2605-2615.
59. van Sorge N.M., Bleumink N.M., van Vliet S.J., Saeland E., van der Pol W.L., van Kooyk Y., van Putten J.P. N-glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL. Cell Microbiol. 2009, 11:1768-1781.
60. van Vliet S.J., Aarnoudse C.A., Broks-van den Berg V.C., Boks M., Geijtenbeek T.B., van Kooyk Y. MGL-mediated internalization and antigen presentation by dendritic cells: a role for tyrosine-5. Eur. J. Immunol. 2007, 37:2075-2081.
61. van Vliet S.J., Bay S., Vuist I.M., Kalay H., Garcia-Vallejo J.J., Leclerc C., van Kooyk Y. MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-alpha secretion. J. Leukoc. Biol. 2013, 94:315-323.
62. van Vliet S.J., Gringhuis S.I., Geijtenbeek T.B., van Kooyk Y. Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45. Nat. Immunol. 2006, 7:1200-1208.
63. van Vliet S.J., Paessens L.C., Broks-van den Berg V.C., Geijtenbeek T.B., van Kooyk Y. The C-type lectin macrophage galactose-type lectin impedes migration of immature APCs. J. Immunol. 2008, 181:3148-3155.
64. van Vliet S.J., Steeghs L., Bruijns S.C., Vaezirad M.M., Snijders B.C., Arenas Busto J.A., Deken M., van Putten J.P., van Kooyk Y. Variation of Neisseria gonorrhoeae lipooligosaccharide directs dendritic cell-induced T helper responses. PLoS Pathog. 2009, 5:e1000625.
65. van Vliet S.J., van Liempt E., Geijtenbeek T.B., van Kooyk Y. Differential regulation of C-type lectin expression on tolerogenic dendritic cell subsets. Immunobiology 2006, 211:577-585.
66. van Vliet S.J., van Liempt E., Saeland E., Aarnoudse C.A., Appelmelk B., Irimura T., Geijtenbeek T.B., Blixt O., Alvarez R., Van Die I., van Kooyk Y. Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells. Int. Immunol. 2005, 17:661-669.
67. van Vliet S.J., Vuist I.M., Lenos K., Tefsen B., Kalay H., Garcia-Vallejo J.J., van Kooyk Y. Human T cell activation results in ERK-Calcineurin dependent exposure of Tn antigen on the cell surface and binding of the Macrophage Galactose-type Lectin (MGL). J. Biol. Chem. 2013, 288:27519-27532.
68. Vukman K.V., Ravida A., Aldridge A.M., O'Neill S.M. Mannose receptor and macrophage galactose-type lectin are involved in Bordetella pertussis mast cell interaction. J. Leukoc. Biol. 2013, 94:439-448.
69. Westcott D.J., Delproposto J.B., Geletka L.M., Wang T., Singer K., Saltiel A.R., Lumeng C.N. MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity. J. Exp. Med. 2009, 206:3143-3156.
70. Yuita H., Tsuiji M., Tajika Y., Matsumoto Y., Hirano K., Suzuki N., Irimura T. Retardation of removal of radiation-induced apoptotic cells in developing neural tubes in macrophage galactose-type C-type lectin-1-deficient mouse embryos. Glycobiology 2005, 15:1368-1375.
71. Zelenay S., Keller A.M., Whitney P.G., Schraml B.U., Deddouche S., Rogers N.C., Schulz O., Sancho D., Reis e Sousa C. The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice. J. Clin. Invest. 2012, 122:1615-1627.